Computing the Future of the Lab
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
Testing Trends-dtet
Dissecting the Data Behind Healthcare AI
How do the underlying datasets affect artificial intelligence tools’ performance in the lab—and beyond?
PGx Testing: First, Do No Harm
Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology
Orgs Plan for Personalized Medicine Growth over Next Few Years
From - Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
Prospective Trial Shows Utility of Liquid Biopsy for Lung Cancer
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Cotesting Best for Cervical Cancer Screening, But Cytology Doesn’t ID Other Gynecological Cancers
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Molecular Profiling of Lung Cancer Tumors Feasible on National Scale
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
Viewpoints Debate Merits of Universal Tumor Sequencing
From - Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…
Non-Public Variant Reporting Hampers Consistency of Sequence Interpretation Between Labs
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Annual Self-Screening With FIT Effective for Colorectal Cancer Detection
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
PSA Testing Patterns Vary By Medical Specialty
From - Diagnostic Testing & Emerging Technologies
Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published online Feb. 8 in…
Testing Trends to Watch for in 2016
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here